Moncrieff, Joanna http://orcid.org/0000-0003-1214-6974
Cooper, Ruth E.
Stockmann, Tom http://orcid.org/0000-0001-9954-1234
Amendola, Simone http://orcid.org/0000-0002-1950-4351
Hengartner, Michael P. http://orcid.org/0000-0002-2956-2969
Plöderl, Martin
Horowitz, Mark A.
Article History
Received: 19 August 2022
Revised: 14 April 2023
Accepted: 21 April 2023
First Online: 16 June 2023
Competing interests
: JM receives royalties for books about psychiatric drugs, and is a co-applicant on the REDUCE trial, funded by the National Institute of Health Research, evaluating digital support for patients stopping long-term antidepressant treatment. She is co-chairperson of the Critical Psychiatry Network (an informal group of psychiatrists) and a board member of the unfunded organisation, the Council for Evidence-based Psychiatry. Both are unpaid positions. MAH reports being a co-founder of Outro Health which provides digital support for patients in Canada and the US to help stop long-term antidepressant treatment using gradual, hyperbolic tapering. MAH and JM are both co-applicants on the RELEASE trial in Australia evaluating hyperbolic tapering of antidepressants against tapering as usual. He is also an Associate of the International Institute for Psychiatric Drug Withdrawal (IIPDW) and a member of the Critical Psychiatry Network. RC is a Board Member of the International Institute for Psychiatric Drug Withdrawal (IIPDW), this is an unpaid position. TS is co-chairperson of the CPN (an unpaid position). MPH receives royalties from Palgrave Macmillan for a book about antidepressants. Other authors report no potential conflicts of interest.